Skip to main content

Nasdaq Stocks

Sinopec's Q4 Earnings Surge, Natural Gas Production Expands

6 years 6 months ago
China Petroleum & Chemical Corporation SNP, also known as Sinopec, reported fourth-quarter 2019 earnings per American Depositary Receipt (ADR) of $1.50. The bottom line was significantly higher than 30 cents per share reported a year ago owing to increased natural gas produc
Zacks

Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children

6 years 6 months ago
Eli Lilly and Company LLY announced that the FDA has approved a supplemental biologics license application (sBLA) for its psoriasis drug Taltz (ixekizumab). Taltz injection (80 mg/mL) is now approved for the treatment of pediatric patients (aged from six to below 18 years) with
Zacks

T-Mobile Awaits Banks' $23B Loan to Close Sprint Transaction

6 years 6 months ago
T-Mobile US, Inc. TMUS will have to secure an aggregate loan worth $23 billion from a group of 16 banks to successfully close its planned merger with Sprint Corp. S, per a Bloomberg report. The deal is planned to be closed as early as Apr 1. Notably, on Mar 19, T-Mobile announce
Zacks

CLINIGEN GP PLC (CLIGF) Upgraded to Strong Buy: Here's Why

6 years 6 months ago
CLINIGEN GP PLC (CLIGF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Zacks

This is Why Essex Property Trust (ESS) is a Great Dividend Stock

6 years 6 months ago
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investme
Zacks

YY vs. HSTM: Which Stock Is the Better Value Option?

6 years 6 months ago
Investors with an interest in Internet - Services stocks have likely encountered both JOYY (YY) and HealthStream (HSTM). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Zacks

BMY or AZN: Which Is the Better Value Stock Right Now?

6 years 6 months ago
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Bristol-Myers Squibb (BMY) and Astrazeneca (AZN). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Zacks
Checked
20 minutes 38 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed